Heterotopic Ossification (HO)
2 clinical trials · Condition
◉ Watch Heterotopic Ossification (HO)
| Record | Firm | Date |
|---|---|---|
| A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton. (NCT07024407) | Ashibio Inc | 2025-05-14 |
| Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP) (NCT04577820) | Regeneron Pharmaceuticals | 2021-10-13 |
Track Heterotopic Ossification (HO) automatically
Every clearance here is in the API, with alerts when new ones post.